Caxton Corporation’s Agile Therapeutics, Inc AGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-907
| Closed | -$4.66M | – | 30 |
|
|
2018
Q1 | $4.66M | Sell |
907
-3
| -0.3% | -$15.4K | 5.06% | 6 |
|
|
2017
Q4 | $4.9M | Hold |
910
| – | – | 5.95% | 5 |
|
|
2017
Q3 | $8.12M | Buy |
910
+98
| +12% | +$874K | 8.26% | 3 |
|
|
2017
Q2 | $6.09M | Hold |
812
| – | – | 9.5% | 2 |
|
|
2017
Q1 | $5.2M | Sell |
812
-250
| -24% | -$1.6M | 14.85% | 2 |
|
|
2016
Q4 | $12.1M | Buy |
1,062
+175
| +20% | +$1.99M | 41.3% | 2 |
|
|
2016
Q3 | $12.4M | Buy |
887
+97
| +12% | +$1.35M | 55.46% | 1 |
|
|
2016
Q2 | $12M | Buy |
790
+76
| +11% | +$1.16M | 13.57% | 2 |
|
|
2016
Q1 | $8.87M | Buy |
714
+702
| +5,850% | +$8.72M | 12.24% | 2 |
|
|
2015
Q4 | $225K | Hold |
12
| – | – | 0.94% | 9 |
|
|
2015
Q3 | $155K | Buy |
12
+3
| +33% | +$38.8K | 0.21% | 15 |
|
|
2015
Q2 | $151K | Sell |
9
-4
| -31% | -$67.1K | 0.16% | 16 |
|
|
2015
Q1 | $248K | Sell |
13
-2
| -13% | -$38.2K | 0.3% | 13 |
|
|
2014
Q4 | $182K | Buy |
15
+1
| +7% | +$12.1K | 0.21% | 6 |
|
|
2014
Q3 | $200K | Buy |
14
+2
| +17% | +$28.6K | 0.21% | 4 |
|
|
2014
Q2 | $217K | Buy |
+12
| New | +$217K | 0.17% | 4 |
|